Fox Paine & Company

Fox Paine & Company is a private equity firm that specializes in management buyouts, build-ups, and strategic reorganizations, with a significant historical focus on the life sciences, healthcare, and agricultural biotechnology sectors. Founded in 1996, the firm is known for taking controlling interests in companies and implementing long-term operational and financial strategies to drive growth. Notable healthcare-related investments include Vicuron Pharmaceuticals (formerly Versicor), which was eventually acquired by Pfizer, and Paradigm, a company focused on genomic-based personalized medicine. The firm typically targets businesses with established market positions and provides the capital and strategic guidance necessary for large-scale expansion or restructuring.